140 related articles for article (PubMed ID: 3926417)
1. [Diagnosis and treatment of Waldenstrom's macroglobulinemia: 4 case reports].
Lu SF; Chen XW; Lin TB
Zhonghua Nei Ke Za Zhi; 1985 Jun; 24(6):358-9, 382-3. PubMed ID: 3926417
[No Abstract] [Full Text] [Related]
2. Waldenström's macroglobulinemia.
Cuttner J
Cancer Invest; 1991; 9(1):107. PubMed ID: 1901510
[No Abstract] [Full Text] [Related]
3. Waldenström's macroglobulinemia: long-term results with the M-2 protocol.
Case DC; Ervin TJ; Boyd MA; Redfield DL
Cancer Invest; 1991; 9(1):1-7. PubMed ID: 1901509
[TBL] [Abstract][Full Text] [Related]
4. Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia.
Carella AM
Haematologica; 1990; 75(6):581. PubMed ID: 1711503
[No Abstract] [Full Text] [Related]
5. Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia.
Dimopoulos MA; Hamilos G; Zervas K; Symeonidis A; Kouvatseas G; Roussou P; Gika D; Karmiris T; Bourantas K; Zomas A; Mitsouli C; Xilouri I; Vervessou E; Matsis K; Anagnostopoulos N; Economopoulos T;
Ann Oncol; 2003 Aug; 14(8):1299-305. PubMed ID: 12881396
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
Montalbán C; Sevilla F; Zapatero A; Blanco L; Sabán J; Serrano M; Serrano Ríos M
Rev Clin Esp; 1985 May; 176(8):392-5. PubMed ID: 3839590
[No Abstract] [Full Text] [Related]
7. Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for Waldenström macroglobulinemia: preliminary report.
Case DC
Blood; 1982 May; 59(5):934-7. PubMed ID: 6803856
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].
Montalbán C; Zapatero A; Blanco L; Sevilla F; García Laraña J; Odriozola J
Sangre (Barc); 1984; 29(6):993-9. PubMed ID: 6549486
[No Abstract] [Full Text] [Related]
9. Endobronchial involvement with Waldenström's macroglobulinemia.
Sakai I; Shiroguchi T; Kanegae H; Matumoto I
Intern Med; 1992 Sep; 31(9):1098-101. PubMed ID: 1421716
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of multiple myeloma].
Golenkov AK
Sov Med; 1991; (3):43-6. PubMed ID: 1882290
[No Abstract] [Full Text] [Related]
11. [Results of the combined treatment of advanced multiple myeloma by the M-2 protocol: cyclophosphamide, vincristine, melphalan, nitrosourea and prednisone].
Gola A; Niewolna M; Weryńska B
Pol Arch Med Wewn; 1987 May; 77(5):200-5. PubMed ID: 3078182
[No Abstract] [Full Text] [Related]
12. Complete remission in plasma cell leukaemia.
Krsnik I; Peñalver MA; Del Potro E; Diaz-Mediavilla J
Br J Haematol; 1987 May; 66(1):145. PubMed ID: 3593651
[No Abstract] [Full Text] [Related]
13. Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysis.
Annibali O; Petrucci MT; Martini V; Tirindelli MC; Levi A; Fossati C; Del Bianco P; Mandelli F; Foa R; Avvisati G
Cancer; 2005 Feb; 103(3):582-7. PubMed ID: 15611977
[TBL] [Abstract][Full Text] [Related]
14. [Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].
Raya Sánchez JM; González Brito G; Marsá Vila L; Brito Barroso ML; Hernández Nieto L
Sangre (Barc); 1991 Oct; 36(5):434-5. PubMed ID: 1816642
[No Abstract] [Full Text] [Related]
15. Alkylating Agents in the Treatment of Waldenström Macroglobulinemia.
Buske C
Hematol Oncol Clin North Am; 2018 Oct; 32(5):821-827. PubMed ID: 30190020
[TBL] [Abstract][Full Text] [Related]
16. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
[TBL] [Abstract][Full Text] [Related]
17. [Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
Sureda A; Pérez de Oteyza J; García Laraña J; Odriozola J
Sangre (Barc); 1989 Jun; 34(3):244. PubMed ID: 2762986
[No Abstract] [Full Text] [Related]
18. Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.
Mohammad RM; al-Katib A; Pettit GR; Sensenbrenner LL
Cancer Res; 1994 Jan; 54(1):165-8. PubMed ID: 8261437
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-based treatments in Waldenström's macroglobulinemia.
Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
[TBL] [Abstract][Full Text] [Related]
20. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
